Is TheraCryf PLC halal to invest in?

According to Musaffa's Shariah screening methodology, TheraCryf PLC (TCF.L) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is TheraCryf PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes TheraCryf PLC using these criteria to determine its compliance status.

Can Muslims buy shares of TheraCryf PLC?

Muslim investors may consider investing in TheraCryf PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is TheraCryf PLC classified as NOT HALAL?

Musaffa determines the Shariah status of TheraCryf PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for TheraCryf PLC updated?

The Shariah compliance status of TheraCryf PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like TheraCryf PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of TheraCryf PLC?

You can check the latest Shariah compliance status of TheraCryf PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

TheraCryf PLC TCF.L

GBX0.24 GBX0.02 (6.00%) 1D

Last Updated: May 15, 12:00 AM·LSE

TCF.L Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 23, 2026

Report Source: 2026 2nd Quarter Report

Analyst's Ratings for TheraCryf PLC (TCF.L)

Based on 9 analysts giving stock ratings to TheraCryf PLC in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

TheraCryf PLC. Stock Analysis TCF.L

United Kingdom Health Care Nano Cap Report: Q2, 2026

TheraCryf Plc is a clinical stage drug development company, which engages in the development of focussing on oncology and neuropsychiatry. The company employs 9 full-time employees The company went IPO on 2015-10-21. The firm has a clinical and preclinical pipeline of indications, including addiction, anxiety, fatigue, narcolepsy, glioblastoma and neurodevelopmental disorders. Its lead program, orexin-1 antagonist, is being developed towards the clinic to target addictive behaviors like binge eating disorder (BED). The company is also advancing a clinical-stage asset, SFX-01, in the fatal brain cancer glioblastoma (GBM). SFX-01 is a patented form of sulforaphane which has shown potential in the treatment of various cancers, neurodevelopmental disorders and other diseases. The company has licensed the global rights for SFX-01 in neurodevelopmental disorders and schizophrenia to Stalicla. The firm also has a candidate molecule dopamine active transport (DAT) inhibitor at a late preclinical stage targeting fatigue and narcolepsy.

Key Statistics of TheraCryf PLC (TCF.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX0.21GBX0.26

Today's Open

GBX0.25

Volume

25.48M

P/E Ratio (TTM)

52 Week Range

GBX0.18GBX0.30

Market Cap

472.77M

Avg. Volume

7.08M

Dividend Yield

Financial Metrics & Statements of TheraCryf PLC (TCF.L)

FAQ's for TheraCryf PLC (TCF.L)

According to Musaffa’s Shariah screening methodology, TheraCryf PLC (TCF.L) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.